Acer Therapeutics Inc. Business Operations Contracts & Agreements

Termination Agreement dated as of August 28, 2023 by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AB (Filed With SEC on August 31, 2023)

Termination Agreement dated as of January 30, 2023 among Acer Therapeutics Inc., the Lenders party thereto and MAM Aardvark, LLC, not individually, but solely in its capacity as... (Filed With SEC on January 31, 2023)

Collaboration and License Agreement, dated March 19, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Filed With SEC on March 22, 2021)

Research Collaboration Agreement, dated March 26, 2020, by and between Acer Therapeutics Inc. and the National Center for Advancing Translational Sciences (Filed With SEC on June 1, 2020)

Amended and Restated Sales Agreement, dated March 18, 2020 by and among Acer Therapeutics Inc., Roth Capital Partners, LLC, and JonesTrading Institutional Services LLC (Filed With SEC on March 18, 2020)

Sales Agreement, dated November 9, 2018, by and between Acer Therapeutics Inc. and Roth Capital Partners, LLC (Filed With SEC on November 9, 2018)

BUSINESS ADVISORY AGREEMENT Prepared For September 2015 ACER THERAPEUTICS INC. BUSINESS ADVISORY AGREEMENT (Filed With SEC on July 19, 2017)

AMENDMENT TO BUSINESS ADVISORY AGREEMENT (Filed With SEC on July 19, 2017)

INDEMNIFICATION AGREEMENT (Filed With SEC on July 19, 2017)

FIRST AMENDMENT TO SALES AGREEMENT (Filed With SEC on March 5, 2014)

TERMINATION AGREEMENT, WAIVER, AND RELEASE (Filed With SEC on April 1, 2013)

PLACEMENT AGENCY AGREEMENT February 7, 2013 (Filed With SEC on February 7, 2013)